Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-21

Clinical Trial Update: Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the food effect of CKD-383 at 0.5/10/1000 mg in healthy volunteers; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CKD-383

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: COMPLETED